Gonapeptyl Depot (Triptorelin)

Gonapeptyl Depot is indicated for several hormone‑dependent conditions where temporary suppression of sex steroids is desired.

• Advanced prostate cancer – reduces testosterone levels to slow tumor growth.
• Endometriosis – lowers estrogen to relieve pelvic pain and limit lesion progression.
• Uterine fibroids – decreases estrogen‑driven fibroid size and controls abnormal uterine bleeding.
• Central precocious puberty – suppresses gonadotropins to delay onset of secondary sexual characteristics.
• Assisted reproductive technology – prevents premature luteinizing hormone surge during controlled ovarian stimulation.

Side effects of Gonapeptyl Depot reflect its hormonal suppression and may vary in frequency and severity.

Common

• Hot flashes or excessive sweating, often occurring during the first weeks of therapy.
• Headache of mild to moderate intensity, which may be intermittent.
• Injection‑site reactions such as pain, redness, or swelling at the administration site.

Serious

• Cardiovascular complications, including new‑onset hypertension or thromboembolic events, especially in patients with pre‑existing risk factors.
• Decreased bone mineral density that can progress to osteoporosis with long‑term use, requiring monitoring.
• Severe allergic reactions ranging from rash to anaphylaxis, which necessitate immediate medical attention.

Before initiating Gonapeptyl Depot, clinicians should evaluate several precautionary factors to minimize risks.

• Assess cardiovascular risk, especially in patients with hypertension or a history of thromboembolism.
• Evaluate bone health; consider calcium and vitamin D supplementation in long‑term therapy.
• Review history of liver disease, as hepatic function may be affected.
• Monitor for signs of adrenal insufficiency, particularly during abrupt discontinuation.
• Use caution in patients with a known hypersensitivity to triptorelin or any excipients.
• Discuss fertility implications and contraceptive needs with patients of reproductive age.

Gonapeptyl Depot can interact with other medicines, altering its efficacy or safety profile.

Avoid

• Concomitant use of other GnRH agonists or antagonists, which may cause excessive hormonal suppression.
• Strong CYP3A4 inducers that could reduce triptorelin levels (e.g., rifampin, carbamazepine).

Use with caution

• Hormone replacement therapies, as combined effects on sex steroids may require dose adjustments.
• Anticoagulants, because hormonal changes can influence clotting risk.
• Medications affecting bone metabolism (e.g., bisphosphonates, glucocorticoids).